<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Salerno D</submitter><funding>Ministero dell’Istruzione, dell’Università e della Ricerca</funding><funding>Università degli Studi di Milano-Bicocca</funding><pagination>2151-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4880801</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>110(10)</volume><pubmed_abstract>Platinum-containing molecules are widely used as anticancer drugs. These molecules exert cytotoxic effects by binding to DNA through various mechanisms. The binding between DNA and platinum-based drugs hinders the opening of DNA, and therefore, DNA duplication and transcription are severely hampered. Overall, impeding the above-mentioned important DNA mechanisms results in irreversible DNA damage and the induction of apoptosis. Several molecules, including multinuclear platinum compounds, belong to the family of platinum drugs, and there is a body of research devoted to developing more efficient and less toxic versions of these compounds. In this study, we combined different biophysical methods, including single-molecule assays (magnetic tweezers) and bulk experiments (ultraviolet absorption for thermal denaturation) to analyze the differential stability of double-stranded DNA in complex with either cisplatin or multinuclear platinum agents. Specifically, we analyzed how the binding of BBR3005 and BBR3464, two representative multinuclear platinum-based compounds, to DNA affects its stability as compared with cisplatin binding. Our results suggest that single-molecule approaches can provide insights into the drug-DNA interactions that underlie drug potency and provide information that is complementary to that generated from bulk analysis; thus, single-molecule approaches have the potential to facilitate the selection and design of optimized drug compounds. In particular, relevant differences in DNA stability at the single-molecule level are demonstrated by analyzing nanomechanically induced DNA denaturation. On the basis of the comparison between the single-molecule and bulk analyses, we suggest that transplatinated drugs are able to locally destabilize small portions of the DNA chain, whereas other regions are stabilized.</pubmed_abstract><journal>Biophysical journal</journal><pubmed_title>Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements.</pubmed_title><pmcid>PMC4880801</pmcid><funding_grant_id>2010LKE4CC</funding_grant_id><pubmed_authors>Brioschi S</pubmed_authors><pubmed_authors>Missana N</pubmed_authors><pubmed_authors>Salerno D</pubmed_authors><pubmed_authors>Zaffaroni N</pubmed_authors><pubmed_authors>Beretta GL</pubmed_authors><pubmed_authors>Cassina V</pubmed_authors><pubmed_authors>Mantegazza F</pubmed_authors><pubmed_authors>Nardo L</pubmed_authors><pubmed_authors>Bellini T</pubmed_authors><pubmed_authors>Cristofalo M</pubmed_authors><pubmed_authors>Tempestini A</pubmed_authors><pubmed_authors>Giovannoni R</pubmed_authors><pubmed_authors>Zanchetta G</pubmed_authors><pubmed_authors>Cerrito MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements.</name><description>Platinum-containing molecules are widely used as anticancer drugs. These molecules exert cytotoxic effects by binding to DNA through various mechanisms. The binding between DNA and platinum-based drugs hinders the opening of DNA, and therefore, DNA duplication and transcription are severely hampered. Overall, impeding the above-mentioned important DNA mechanisms results in irreversible DNA damage and the induction of apoptosis. Several molecules, including multinuclear platinum compounds, belong to the family of platinum drugs, and there is a body of research devoted to developing more efficient and less toxic versions of these compounds. In this study, we combined different biophysical methods, including single-molecule assays (magnetic tweezers) and bulk experiments (ultraviolet absorption for thermal denaturation) to analyze the differential stability of double-stranded DNA in complex with either cisplatin or multinuclear platinum agents. Specifically, we analyzed how the binding of BBR3005 and BBR3464, two representative multinuclear platinum-based compounds, to DNA affects its stability as compared with cisplatin binding. Our results suggest that single-molecule approaches can provide insights into the drug-DNA interactions that underlie drug potency and provide information that is complementary to that generated from bulk analysis; thus, single-molecule approaches have the potential to facilitate the selection and design of optimized drug compounds. In particular, relevant differences in DNA stability at the single-molecule level are demonstrated by analyzing nanomechanically induced DNA denaturation. On the basis of the comparison between the single-molecule and bulk analyses, we suggest that transplatinated drugs are able to locally destabilize small portions of the DNA chain, whereas other regions are stabilized.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 May</publication><modification>2025-05-18T13:45:31.602Z</modification><creation>2025-05-18T13:45:31.602Z</creation></dates><accession>S-EPMC4880801</accession><cross_references><pubmed>27224480</pubmed><doi>10.1016/j.bpj.2016.02.030</doi></cross_references></HashMap>